Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

08.12.2025

1 Am J Respir Crit Care Med
1 Ann Intern Med
1 Biochemistry
1 Chemotherapy
1 Curr Microbiol
17 J Antimicrob Chemother
2 J Infect Dis
1 J Med Chem
1 JAMA
1 Nature
4 Pediatrics
2 PLoS Negl Trop Dis
4 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A


    Am J Respir Crit Care Med

  1. XIAO K, Cao Y, Yan P, Hu Y, et al
    A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia.
    Am J Respir Crit Care Med. 2025;211:2363-2381.
    >> Share


    Ann Intern Med

  2. FREEDMAN DO
    Asheville, North Carolina: The Origin of the American Tuberculosis Sanitarium Movement.
    Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-02861.
    >> Share


    Biochemistry

  3. HYATT BL, Rodrigo MKD, Barnett TC
    Impact of Host and Bacterial Metabolism on Antibiotic Susceptibility.
    Biochemistry. 2025;64:4555-4564.
    >> Share


    Chemotherapy

  4. GATTI M, Cojutti PG, Pea F
    Role of a Therapeutic Drug Monitoring-Guided Strategy of Isavuconazole for Optimizing Efficacy/Safety Outcomes in Onco-Hematological Pediatric Patients: A Systematic Review.
    Chemotherapy. 2025;70:163-176.
    >> Share


    Curr Microbiol

  5. SINGH S, Dubal ZB, Kumar GR, Tamta S, et al
    Genomic Constellation of Foodborne Proteus Mirabilis Isolates Harboring AMR, Virulence Genes and Comparative WGS Analysis.
    Curr Microbiol. 2025;83:54.
    >> Share


    J Antimicrob Chemother

  6. BALTAS I, Tsakri D, Vourli S, Solanki H, et al
    Comparative evaluation of disc diffusion and broth microdilution methods for aztreonam/avibactam susceptibility testing in Enterobacterales.
    J Antimicrob Chemother. 2025;80:3273-3277.
    >> Share

  7. MA J, van Doodewaerd BR, Biersack B, Verbon A, et al
    A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-kappaB inhibitors active against eumycetoma.
    J Antimicrob Chemother. 2025;80:3320-3328.
    >> Share

  8. BLANCO-MARTIN T, Guzman-Puche J, Hernandez-Garcia M, Munoz-Rosa M, et al
    Mechanisms of resistance to ceftazidime/avibactam in mutants derived in vitro from Klebsiella pneumoniae producing OXA-48-like enzymes.
    J Antimicrob Chemother. 2025;80:3265-3272.
    >> Share

  9. IACHKINE J, Alexandre K, Marlat C, Briant A, et al
    Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study.
    J Antimicrob Chemother. 2025 Sep 30:dkaf370. doi: 10.1093.
    >> Share

  10. CINCOTTA SE, Ostrowsky BE, Howard-Anderson J, Beekmann SE, et al
    Treatment preferences by infectious diseases clinicians for carbapenem-resistant Enterobacterales infections.
    J Antimicrob Chemother. 2025 Sep 30:dkaf371. doi: 10.1093.
    >> Share

  11. LAI CC, Liu CY, Huang KJ, Huang YT, et al
    Global susceptibility profiles and potential resistance mechanisms of ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and Surveillance.
    J Antimicrob Chemother. 2025 Oct 7:dkaf375. doi: 10.1093.
    >> Share

  12. PELLEGRINO C, Veronese N, De Santis L, Amendolara A, et al
    Frailty Index Laboratory (FI-Lab) as predictor of poor outcomes for intra-hospital multidrug-resistant Klebsiella pneumoniae bloodstream infections: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2025;80:3257-3264.
    >> Share

  13. SMITH S, Reilly CW, Stewart J, Ragh T, et al
    Thrice-weekly post-haemodialysis ceftazidime can achieve adequate pre-dialysis concentrations and clinical cure in patients with melioidosis.
    J Antimicrob Chemother. 2025;80:3386-3390.
    >> Share

  14. MULLER SE, Junker S, Rehner J, Forster M, et al
    Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2025;80:3352-3356.
    >> Share

  15. ORENBUCH-HARROCH E, Snoyman G, Nashashibi MA, Temper V, et al
    Aztreonam-amoxicillin/clavulanate combination therapy against blaNDM-producing Enterobacterales infections.
    J Antimicrob Chemother. 2025;80:3375-3380.
    >> Share

  16. VAN RHIJN N, White PL
    Antifungal treatment strategies and their impact on resistance development in clinical settings.
    J Antimicrob Chemother. 2025;80:3208-3226.
    >> Share

  17. ZHANG H, Liang B, Tan Z, Wang R, et al
    The synergistic activity of tigecycline-based combinations against multidrug-resistant Acinetobacter baumannii-caused bloodstream infections.
    J Antimicrob Chemother. 2025;80:3407-3418.
    >> Share

  18. NEOH CF, Yong MK, Rowley L, Roberts AW, et al
    Antifungal prophylaxis in patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive acute myeloid leukaemia receiving sorafenib during initial induction and consolidation treatment in ALLG AMLM16 trial.
    J Antimicrob Chemother. 2025;80:3401-3406.
    >> Share

  19. FU Y, Fouad A, Roenfanz HF, Nicolau DP, et al
    Efficacy of human-simulated aztreonam-avibactam against Stenotrophomonas maltophilia in the neutropenic murine thigh infection model.
    J Antimicrob Chemother. 2025;80:3431-3437.
    >> Share

  20. REZZOUG I, Ouacel K, Droit T, Ronsin S, et al
    Therapeutic challenges in treating ESBL- and/or AmpC-producing non-carbapenemase-producing Enterobacterales: an in vitro evaluation of novel beta-lactam/beta-lactamase inhibitor combinations and cefiderocol.
    J Antimicrob Chemother. 2025;80:3297-3305.
    >> Share

  21. PALACIOS R, Gomez-Ayerbe C, Martin-Cortes S, Gonzalez-Jimenez A, et al
    Post-exposure prophylaxis with doxycycline (DoxyPEP) to prevent STIs in a real-world setting: the PRIDOX study.
    J Antimicrob Chemother. 2025;80:3306-3310.
    >> Share

  22. CANAS MA, Cuervo G, Garcia-Gonzalez J, Krivak F, et al
    In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditis.
    J Antimicrob Chemother. 2025 Dec 4:dkaf435. doi: 10.1093.
    >> Share


    J Infect Dis

  23. BUNJUN R, Lurie M, Dabee S, Barnabas S, et al
    Chlamydia trachomatis-specific T Cell Immunity Reflects Widespread Exposure in South African Adolescents and Young Women.
    J Infect Dis. 2025 Dec 3:jiaf595. doi: 10.1093.
    >> Share

  24. JANSSEN NAF, Bruno M, Berk Y, Reijers MHE, et al
    Interferon-gamma production defects characterise immune responses in patients with chronic pulmonary aspergillosis.
    J Infect Dis. 2025 Nov 29:jiaf596. doi: 10.1093.
    >> Share


    J Med Chem

  25. KUMAR TA, Birua S, Mallojjala SC, Mukherjee P, et al
    A Mycobacteria-Specific Prodrug to Overcome Phenotypic AMR in Mycobacterium tuberculosis.
    J Med Chem. 2025 Dec 1. doi: 10.1021/acs.jmedchem.5c01848.
    >> Share


    JAMA

  26. CHEVALIER FJ, Bacon O, Johnson KA, Cohen SE, et al
    Syphilis: A Review.
    JAMA. 2025 Oct 16. doi: 10.1001/jama.2025.17362.
    >> Share


    Nature

  27. LUCHETTI G, Miner MV, Peterson RM, Scott WP, et al
    Enteropathogenic bacteria evade ROCK-driven epithelial cell extrusion.
    Nature. 2025;648:166-172.
    >> Share


    Pediatrics

  28. LIU J, Chow T
    Diagnosing Paediatric Mild Acute Food Protein-Induced Enterocolitis Syndrome: Proposal of New Criteria.
    Pediatrics. 2025;156.
    >> Share

  29. LE T, Gupta M
    The Prevalence of Peanut-Triggered Food Protein-Induced Enterocolitis Syndrome in a Prospective Cohort of Infants Introducing Peanut in the First Year of Life.
    Pediatrics. 2025;156.
    >> Share

  30. SANDERS JM, Shaker MS
    Oral Food Challenge Protocols in Food Protein-Induced Enterocolitis Syndrome: A Systematic Review.
    Pediatrics. 2025;156.
    >> Share

  31. KAMDAR S, Sicherer SH
    Resolution of Food Protein-Induced Enterocolitis Syndrome-A Long-Term Follow-Up Study of 113 Swedish Children.
    Pediatrics. 2025;156.
    >> Share


    PLoS Negl Trop Dis

  32. LE TURNIER P, Oberlis M, Lavergne A, Epelboin L, et al
    Leptospirosis seroprevalence and exposure factors in three informal settlements of French Guiana: An opportunistic survey.
    PLoS Negl Trop Dis. 2025;19:e0013764.
    >> Share

  33. RASOLOFOZAFY H, Ronse M, Andrianiriana LMJ, Andriamira R, et al
    Leprosy perceptions and health seeking behaviour in Miandrivazo district, Madagascar.
    PLoS Negl Trop Dis. 2025;19:e0013212.
    >> Share


    PLoS One

  34. MARGINEANU I, Gafar F, Butnaru T, Baiceanu D, et al
    Factors influencing drug-susceptible tuberculosis treatment outcomes in Romania and Ukraine.
    PLoS One. 2025;20:e0337937.
    >> Share

  35. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Correction: Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.
    PLoS One. 2025;20:e0338017.
    >> Share

  36. NGWIRA A, Manda SOM, Karimuribo ED, Kimera SI, et al
    JSTMapp: A web-based joint spatiotemporal modelling and mapping application for epidemiologists.
    PLoS One. 2025;20:e0332607.
    >> Share


  37. Retraction: Investigating the association between Candida albicans and early childhood dental caries: A comprehensive systematic review and meta-analysis.
    PLoS One. 2025;20:e0337750.
    >> Share


    PLoS Pathog

  38. MOTTA C, Turley M, Barbieri G, Fama A, et al
    A single amino acid substitution in Fibronectin Binding protein A (FnBPA) governs Staphylococcus aureus virulence via host transglutaminase-mediated fibrin crosslinking.
    PLoS Pathog. 2025;21:e1013743.
    >> Share


    Proc Natl Acad Sci U S A

  39. ESTEVES NC, Tao R, Pu Q, Banerjee A, et al
    Nitric oxide promotes rapid development of motility to accelerate biofilm dispersal in Vibrio cholerae.
    Proc Natl Acad Sci U S A. 2025;122:e2526864122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016